Alphatec Holdings, Inc.
Every calculator, already run for ATEC
Open the full toolkit →You have the numbers on ATEC. Get the argument.
A written report on which of these readings actually decide the outcome for Alphatec Holdings, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
14 analysts covering ATECAnalyst Price Target Disagreement for Alphatec Holdings, Inc.
Wall Street's bull case implies +137% from the current price; the bear case implies +19%. A 119% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for ATEC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Position…
ATEC — frequently asked
Is ATEC a buy right now?
Wall Street's consensus rating on Alphatec Holdings, Inc. is none across 14 analysts, with a mean price target of $15.79 (+56% vs. the current $10.12). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is ATEC overvalued?
ATEC trades at — trailing earnings, against a DCF fair value of $9 per share. The current price implies 8% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is ATEC's next earnings date?
Alphatec Holdings, Inc. is next scheduled to report earnings around Oct 29, 2026. A full ATEC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Alphatec Holdings, Inc.?
Analysts covering Alphatec Holdings, Inc. (ATEC) range from a bear-case target of $12.00 to a bull-case high of $24.00, with a mean consensus target of $15.79 across 14 analysts. The spread of $12.00 (119% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Alphatec Holdings, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Alphatec Holdings, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full ATEC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Alphatec Holdings, Inc., in minutes. 3 free reports included with every account — no credit card required.